Financial and Investment Analysts H-1B salary at AstraZeneca Pharmaceuticals LP: $161,500 average ($148,000-$175,000 range). 100% approval rate.
AstraZeneca Pharmaceuticals LP has sponsored 2 H-1B petitions for Financial and Investment Analysts roles, with salaries ranging from $148k to $175k. The average offered salary of $162k is 25% above the prevailing wage for this occupation. Most positions are located in Connecticut (50%), Massachusetts (50%). The certification rate is 100%. 50% of these filings are for new employment.
| Total Filings | 2 |
| Approval Rate | 100% |
| Average Salary | $161,500 |
| Median Salary | $175,000 |
| 25th Percentile | $148,000 |
| 75th Percentile | $175,000 |
| Minimum Salary | $148,000 |
| Maximum Salary | $175,000 |
100% of filings offer salaries above the prevailing wage, with an average premium of 25%. The average prevailing wage is $132k (based on 2 filings with prevailing wage data).
Average processing time is 7 days (median: 7 days). Fastest: 7 days, slowest: 7 days. Based on 2 filings.
50% of filings are for new positions, while 0% are for continued employment (2 filings with data).
Average contract duration: 36 months (median: 36 months), based on 2 filings.
| Education Level | Filings |
|---|---|
| Not Specified | 2 |
| State | Filings |
|---|---|
| Connecticut | 1 |
| Massachusetts | 1 |
AstraZeneca Pharmaceuticals LP has 2 H-1B filings for Financial and Investment Analysts positions in our database of DOL public records.
The average H-1B salary for Financial and Investment Analysts at AstraZeneca Pharmaceuticals LP is $161,500, with a median of $175,000. Salaries range from $148,000 to $175,000.
The H-1B approval rate for Financial and Investment Analysts positions at AstraZeneca Pharmaceuticals LP is 100% based on 2 DOL filings.
See how Financial and Investment Analysts salaries compare across different H-1B sponsors.